What is the recommended Flonase (fluticasone propionate) dosing schedule for rhinitis in adults and children (ages ≥12, 4‑11, and 2‑3) based on severity?

Flonase (Fluticasone Propionate) Dosing for Rhinitis

For adults and adolescents ≥12 years with rhinitis, start with 2 sprays per nostril once daily (200 mcg total); for children ages 4–11 years, use 1 spray per nostril once daily (100 mcg total); and for children ages 2–3 years, fluticasone propionate is not FDA-approved—use mometasone furoate or fluticasone furoate instead. 1

Age-Specific Dosing Recommendations

Adults and Adolescents (≥12 years)

• Standard dose: 2 sprays per nostril once daily (200 mcg total daily dose) 1
• Severe congestion: May temporarily increase to 2 sprays per nostril twice daily (400 mcg total) until symptoms are controlled, then reduce to maintenance dosing 2
• Onset: Symptom relief begins within 3–12 hours, with maximal efficacy reached over days to weeks of continuous use 2

Children Ages 4–11 Years

• Recommended dose: 1 spray per nostril once daily (100 mcg total daily dose) 1, 3, 4
• This half-adult dose is equally effective as the 200 mcg dose in pediatric trials and is the FDA-approved starting dose for this age group 3, 4
• Studies demonstrate no interference with the hypothalamic-pituitary-adrenal axis at this dosing 3, 4

Children Ages 2–3 Years

• Fluticasone propionate (Flonase) is NOT approved for children under 4 years of age 1
• Alternative options:
  • Mometasone furoate (Nasonex): 1 spray per nostril daily, approved for ages ≥2 years 1, 2
  • Fluticasone furoate (Veramyst): 1–2 sprays per nostril daily, approved for ages ≥2 years 1, 5

Treatment Duration and Approach

Continuous vs. As-Needed Use

• Use daily and continuously throughout allergen exposure, not on an as-needed basis 2, 6
• For seasonal allergic rhinitis, continue throughout the entire allergy season 2, 6
• For perennial allergic rhinitis, year-round daily therapy is required due to unavoidable ongoing allergen exposure 2, 7

Minimum Trial Period

• Continue for at least 8–12 weeks to adequately assess therapeutic benefit 2
• Counsel patients that full benefit may not be evident for the first 2 weeks of treatment 2

Administration Technique to Minimize Side Effects

Critical technique points to reduce epistaxis risk by fourfold: 2

• Use the contralateral hand (right hand for left nostril, left hand for right nostril) to direct spray away from the nasal septum 2
• Shake the bottle before each use 2, 5
• Have patient blow nose prior to administration 2, 5
• Keep head upright during spraying 2, 5
• Do not close the opposite nostril during administration 2
• If using nasal saline irrigations, perform them before the steroid spray 2

Safety Profile

Systemic Safety (All Ages)

• No HPA axis suppression at recommended doses in children or adults 2, 3, 4, 7
• No effect on growth in children at approved doses (100–200 mcg daily) 2, 3, 4
• No ocular complications (cataracts, glaucoma) with long-term use 2
• Safe for continuous use up to 52 weeks without systemic effects 2, 7

Common Local Side Effects

• Epistaxis (blood-tinged nasal secretions): most common adverse event, occurring in 4–20% depending on duration 1, 2
• Headache, pharyngitis, nasal burning/irritation, nausea, cough 1, 2
• These local effects can be minimized with proper spray technique 2

Contraindications

• History of hypersensitivity to fluticasone propionate or any formulation component 1, 2

Monitoring During Long-Term Use

• Examine nasal septum every 6–12 months to detect mucosal erosions that may precede septal perforation (rare complication) 2
• No routine laboratory monitoring required for HPA axis or growth parameters 2

When to Escalate Therapy

If inadequate response after 2–4 weeks of fluticasone propionate monotherapy: 2

• Add intranasal antihistamine (azelastine) for >40% relative improvement compared to either agent alone 2
• Do NOT add oral antihistamines—they provide no additional nasal symptom benefit when intranasal corticosteroid is already in use 2

For severe initial congestion: 2

• May add a topical decongestant for 3–5 days maximum while initiating fluticasone propionate 2
• Topical decongestants must be limited to 3 days to avoid rebound congestion (rhinitis medicamentosa) 2

Common Clinical Pitfalls to Avoid

• Do not delay initiation while awaiting allergy testing results—start immediately upon clinical diagnosis 2
• Do not prescribe for children under 4 years—use age-appropriate alternatives (mometasone or fluticasone furoate) 1, 2
• Do not recommend as-needed use—continuous daily therapy is essential for efficacy 2, 6
• Do not combine with oral antihistamines as initial therapy—intranasal corticosteroid monotherapy is equally effective and more cost-efficient 2
• Do not use beclomethasone dipropionate in children—it is associated with growth suppression at standard doses 2